A prospective single-centre evaluation of the intra-individual variability of faecal calprotectin in quiescent Crohn's disease-Reference-Cited by-同舟云学术

A prospective single-centre evaluation of the intra-individual variability of faecal calprotectin in quiescent Crohn's disease

Published:2013-01-24 Issue:6 Volume:37 Page:613-621
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Naismith G. D.¹,Smith L. A.¹,Barry S. J. E.²,Munro J. I.¹,Laird S.¹,Rankin K.³,Morris A. J.¹,Winter J. W.¹,Gaya D. R.¹

Affiliation:

1. Department of Gastroenterology; Glasgow Royal Infirmary; Glasgow; UK

2. Robertson Centre for Biostatistics; Institute of Health and Wellbeing; University of Glasgow; Glasgow; UK

3. Department of Clinical Biochemistry; Glasgow Royal Infirmary; Glasgow; UK

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.12221/fullpdf

Reference34 articles.

1. A simple method for assessing intestinal inflammation in Crohn's disease;Tibble;Gut,2000

2. Faecal calprotectin: marker of inflammation throughout the intestinal tract;Summerton;Eur J Gastroenterol Hepatol,2002

3. Fecal Calprotectin correlates more closely with with simple endoscopic score for Crohn's disease (SES-CD) than CRP, Leukocytes and the CDAI;Schoepfer;Inflamm Bowel Dis,2010

4. Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein in patients with inflammatory bowel disease;Roseth;Scand J Gastroenterol,1999

5. Assessment of the neutrophil dominating protein calprotectin in feces A methodologic study;Roseth;Scand J Gastroenterol,1992

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors associated with cam deformity in Japanese local residents;Scientific Reports;2024-01-18

2. Validation of rapid fecal calprotectin assay using particle enhanced turbidimetric immunoassay for inflammatory bowel disease;Scientific Reports;2024-01-18

3. Role of Fecal Calprotectin in Patients Presenting to the Emergency Department with Abdominal Pain with or without Diarrhea or Rectal Bleeding;Reviews on Recent Clinical Trials;2023-10-26

4. Plasminogen Activator Inhibitor 1 Is a Novel Faecal Biomarker for Monitoring Disease Activity and Therapeutic Response in Inflammatory Bowel Diseases;Journal of Crohn's and Colitis;2023-09-26

5. Validation of Rapid Fecal Calprotectin Assay “fCAL turbo” for Inflammatory Bowel Disease – Retrospective Comparative Study with Endoscopic Activity;2023-04-25